ADC Therapeutics SA

ADCT·NYSE·$3.51Share Price as of 11/2·$446MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/04/26 10-KFY 202503/10/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/13/26 8-KCurrent report08/13/26 8-KCurrent report07/02/26 8-KCurrent report06/24/26 8-KCurrent report06/03/26

Prospectuses and Registrations

S-8Registration of securities for employees08/13/26 424B3Prospectus04/15/26 424B3Prospectus03/16/26 S-3Shelf registration03/10/26 424B3Prospectus12/12/25

Proxies

DEF 14ADefinitive proxy04/20/26 DEFA14AAdditional proxy materials04/20/26 PRE 14APreliminary proxy04/10/26 DEF 14ADefinitive proxy04/21/25 DEFA14AAdditional proxy materials04/21/25

Ownership

SC 13GBeneficial ownership10/29/26 SC 13GBeneficial ownership08/14/26 Form 4Insider transaction07/02/26 Form 4Insider transaction07/02/26 Form 4Insider transaction07/02/26

Other

EFFECTRequest for effectiveness03/16/26 CORRESPCorrespondence with the SEC03/12/26 UPLOADLetter from the SEC03/12/26 ARSAnnual report to shareholders03/10/26 EFFECTRequest for effectiveness12/12/25